Document is current

Any future updates will be listed below

Response to letter regarding article, humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity (IEI) or mannan-binding lectin (MBL) deficiency—A prospective controlled open-label trial: correspondence

Crossref DOI link: https://doi.org/10.1007/s00508-024-02482-7

Published Online: 2024-12-11

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark